| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $14.47M | - | |
| Dir | 207.5K | $2.96M | - | |
| Dir | 134.7K | $1.92M | - | |
| VP | 121.2K | $1.73M | - | |
| VP | 101.5K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Dube Michael P53 | VP, Chief Accounting Officer | Sell | 1,372 | $12.18 | $16,710.96 | -2.9% | -43.2% | -24.1% | |
| Jan 3, 2025 | Hicks Derek71 | EVP, Chief Business Officer | Sell | 6,502 | $12.18 | $79,194.36 | -9.8% | -43.2% | -24.1% | |
| Jan 3, 2025 | Leonard John M83 | President And CEO | Sell | 26,807 | $12.18 | $326,509.26 | -2.8% | -43.2% | -24.1% | |
| Jan 3, 2025 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sell | 8,966 | $12.18 | $109,205.88 | -10.4% | -43.2% | -24.1% | |
| Jan 3, 2025 | Basta James72 | EVP, General Counsel | Sell | 7,074 | $12.18 | $86,161.32 | -8.7% | -43.2% | -24.1% | |
| Jan 3, 2025 | Lebwohl David87 | EVP, Chief Medical Officer | Sell | 9,557 | $12.18 | $116,404.26 | -9.8% | -43.2% | -24.1% | |
| Jan 3, 2025 | Clark Eliana78 | EVP, Chief Technical Officer | Sell | 7,978 | $12.17 | $97,088.64 | -5.6% | -43.2% | -24.1% | |
| Oct 2, 2024 | Dube Michael P53 | VP, Chief Accounting Officer | Sell | 2,012 | $19.01 | $38,248.12 | -4.1% | -37.1% | +10.2% | |
| Jul 1, 2024 | Clark Eliana78 | EVP, Chief Technical Officer | Sell | 405 | $22.93 | $9,286.65 | -0.6% | -8.5% | -56.0% | |
| Jun 17, 2024 | Verwiel Frank | Director | Sell | 1,505 | $25.00 | $37,625.00 | -7.7% | -14.5% | -61.9% |